US FDA authorises marketing of first eyeglass lenses to slow progression of paediatric myopia

The US Food and Drug Administration (FDA) has authorised marketing of the Essilor Stellest eyeglass lenses to correct myopia, commonly referred to as nearsightedness, with or without astigmatism and to slow the progression of the disease in children 6 to 12 years old at the initiation of treatment.

- 

According to the National Eye Institute, several studies indicate that the prevalence of myopia is increasing in the US and worldwide, and researchers project the trend will continue in the coming decades. Myopia is a chronic d